These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 36961395)

  • 1. The cell senescence regulator p16 is a promising cancer prognostic and immune check-point inhibitor (ICI) therapy biomarker.
    Tu Z; Wang X; Cai H; Sheng Y; Wu L; Huang K; Zhu X
    Aging (Albany NY); 2023 Mar; 15(6):2136-2157. PubMed ID: 36961395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein Disulfide-Isomerase A3 Is a Robust Prognostic Biomarker for Cancers and Predicts the Immunotherapy Response Effectively.
    Tu Z; Ouyang Q; Long X; Wu L; Li J; Zhu X; Huang K
    Front Immunol; 2022; 13():837512. PubMed ID: 35401558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sperm Autoantigenic Protein 17 Predicts the Prognosis and the Immunotherapy Response of Cancers: A Pan-Cancer Analysis.
    Tu Z; Peng J; Long X; Li J; Wu L; Huang K; Zhu X
    Front Immunol; 2022; 13():844736. PubMed ID: 35592314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive analyses of cuproptosis-related gene CDKN2A on prognosis and immunologic therapy in human tumors.
    Zhang D; Wang T; Zhou Y; Zhang X
    Medicine (Baltimore); 2023 Apr; 102(14):e33468. PubMed ID: 37026918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Comprehensive Pan-Cancer Analysis Reveals Cyclin-Dependent Kinase Inhibitor 2A Gene as a Potential Diagnostic and Prognostic Biomarker in Colon Adenocarcinoma.
    Salem A; Ahmed S; Khalfallah M; Hamadan N; ElShikh W; Alfaki M
    Cureus; 2024 May; 16(5):e60586. PubMed ID: 38894777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pan-cancer analysis of CDKN2A alterations identifies a subset of gastric cancer with a cold tumor immune microenvironment.
    Deng C; Li ZX; Xie CJ; Zhang QL; Hu BS; Wang MD; Mei J; Yang C; Zhong Z; Wang KW
    Hum Genomics; 2024 May; 18(1):55. PubMed ID: 38822443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Death associated protein kinase 1 predicts the prognosis and the immunotherapy response of various cancers.
    Yang J; Liu Y; Geng Q; Wang B
    Mol Biol Rep; 2024 May; 51(1):670. PubMed ID: 38787485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implications of Genetic and Epigenetic Alterations of CDKN2A (p16(INK4a)) in Cancer.
    Zhao R; Choi BY; Lee MH; Bode AM; Dong Z
    EBioMedicine; 2016 Jun; 8():30-39. PubMed ID: 27428416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures.
    Zhang X; Wang Y; A G; Qu C; Chen J
    Front Immunol; 2021; 12():721030. PubMed ID: 34531868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CDKN2A-mediated molecular subtypes characterize the hallmarks of tumor microenvironment and guide precision medicine in triple-negative breast cancer.
    Cheng T; Wu Y; Liu Z; Yu Y; Sun S; Guo M; Sun B; Huang C
    Front Immunol; 2022; 13():970950. PubMed ID: 36052076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive pan-cancer investigation: unraveling the oncogenic, prognostic, and immunological significance of Abelson interactor family member 3 gene in human malignancies.
    Sun A; Cai F; Xiong Q; Xie T; Li X; Xie Y; Luo R; Hu W; Zhong F; Wang S
    Front Mol Biosci; 2023; 10():1277830. PubMed ID: 37942289
    [No Abstract]   [Full Text] [Related]  

  • 12. Transcriptional regulation of
    Rodríguez S; Bermúdez LG; González D; Bernal C; Cañas A; Morales-Ruíz T; Henríquez B; Rojas A
    Mol Med Rep; 2022 Nov; 26(5):. PubMed ID: 36169180
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Adib E; Nassar AH; Akl EW; Abou Alaiwi S; Nuzzo PV; Mouhieddine TH; Sonpavde G; Haddad RI; Mouw KW; Giannakis M; Hodi FS; Shukla SA; Gusev A; Braun DA; Choueiri TK; Kwiatkowski DJ
    Clin Cancer Res; 2021 Jul; 27(14):4025-4035. PubMed ID: 34074656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensively prognostic and immunological analysis of snail family transcriptional repressor 2 in pan-cancer and identification in pancreatic carcinoma.
    Zhang D; Jiang Z; Hu J; Sun X; Zheng Y; Shen Y
    Front Immunol; 2023; 14():1117585. PubMed ID: 37251370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pan-cancer analysis: predictive role of TAP1 in cancer prognosis and response to immunotherapy.
    Tu Z; Li K; Ji Q; Huang Y; Lv S; Li J; Wu L; Huang K; Zhu X
    BMC Cancer; 2023 Feb; 23(1):133. PubMed ID: 36759763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Four-Cell-Senescence-Regulator-Gene Prognostic Index Verified by Genome-Wide CRISPR Can Depict the Tumor Microenvironment and Guide Clinical Treatment of Bladder Cancer.
    Sun JX; Liu CQ; Xu JZ; An Y; Xu MY; Zhong XY; Zeng N; Ma SY; He HD; Zhang ZB; Wang SG; Xia QD
    Front Immunol; 2022; 13():908068. PubMed ID: 35898492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive role of E2F6 in cancer prognosis and responses of immunotherapy.
    Gong C; Tu Z; Long X; Liu X; Liu F; Liu J; Zhu X; Li J; Huang K
    Int Immunopharmacol; 2024 Jan; 127():111302. PubMed ID: 38071912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CDK16 as a potential prognostic biomarker correlated with an immunosuppressive tumor microenvironment and benefits in enhancing the effectiveness of immunotherapy in human cancers.
    Qi J; Wu G; He M; Xu Y; Yang Z; Ding L; Wang Y; Zhang Z
    Aging (Albany NY); 2024 Jan; 16(2):1879-1896. PubMed ID: 38261737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive Analysis Revealed that
    Chen Z; Guo Y; Zhao D; Zou Q; Yu F; Zhang L; Xu L
    Front Cell Dev Biol; 2021; 9():808208. PubMed ID: 35004697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of cell senescence molecular subtypes in prediction of the prognosis and immunotherapy of hepatitis B virus-related hepatocellular carcinoma.
    Yu X; Chen P; Yi W; Ruan W; Xiong X
    Front Immunol; 2022; 13():1029872. PubMed ID: 36275676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.